On May 22, 2025, Castle Biosciences Inc. held its annual stockholder meeting where amendments to limit officer liability were approved, alongside the election of new directors and selection of KPMG as auditors for 2025. The amendments and election results highlight the company's governance updates and strategic planning efforts.